Kadiyala; Irina Nikolaevna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kadiyala; Irina Nikolaevna.The latest application filed is for "pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof".

Company Profile

7.15.33

Kadiyala; Irina Nikolaevna - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 11,390,600 - DeCrescenzo , et al. July 19, 2	2022-07-19
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof App 20220031679 - VERWIJS; Marinus Jacobus ; et al.	2022-02-03
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof Grant 11,052,075 - Verwijs , et al. July 6, 2	2021-07-06
CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20200339531 - DeCrescenzo; Gary ; et al.	2020-10-29
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 10,738,027 - DeCrescenzo , et al. A	2020-08-11
Co-crystals and pharmaceutical compositions comprising the same Grant 10,716,789 - Nti-Addae , et al.	2020-07-21
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Ben App 20200197380 - Verwijs; Marinus Jacobus ; et al.	2020-06-25
CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20190127348 - DeCrescenzo; Gary ; et al.	2019-05-02
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof App 20190070155 - VERWIJS; Marinus Jacobus ; et al.	2019-03-07
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 10,183,927 - DeCrescenzo , et al. Ja	2019-01-22
Co-crystals And Pharmaceutical Compositions Comprising The Same App 20180325897 - Nti-Addae; Kwame Wiredu ; et al.	2018-11-15
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof Grant 10,076,513 - Verwijs , et al. September 18, 2	2018-09-18
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof Grant 10,058,546 - Alargova , et al. August 28, 2	2018-08-28
Co-crystals and pharmaceutical compositions comprising the same Grant 10,039,761 - Nti-Addae , et al. August 7, 2	2018-08-07
CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20170320851 - DeCrescenzo; Gary ; et al.	2017-11-09
Pharmaceutical Compositions of (R)-1-(2,2-Difluorobenzo[D] [1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-meth- ylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarbox-amide and Administration Thereof App 20170266176 - Alargova; Rossitza Gueorguieva ; et al.	2017-09-21
Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 9,676,746 - DeCrescenzo , et al. June 13, 2	2017-06-13
Co-crystals And Pharmaceutical Compositions Comprising The Same App 20160339024 - Nti-Addae; Kwame Wiredu ; et al.	2016-11-24
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof. App 20160303096 - VERWIJS; MARINUS JACOBUS ; et al.	2016-10-20
CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20160221987 - DeCrescenzo; Gary ; et al.	2016-08-04
Pharmaceutical Compositions And Administrations Thereof App 20160067239 - Van Goor; Fredrick F. ; et al.	2016-03-10
Pharmaceutical Compositions and Administrations Thereof App 20160022665 - Van Goor; Fredrick F. ; et al.	2016-01-28
Pharmaceutical Compositions and Administrations Thereof App 20160022664 - Van Goor; Fredrick F. ; et al.	2016-01-28
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof Grant 9,241,934 - Verwijs , et al. January 26, 2	2016-01-26
Pharmaceutical Compositions of (R)-1-(2,2-Difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and Administration Thereof App 20150182517 - Alargova; Rossitza Gueorguieva ; et al.	2015-07-02
Pharmaceutical Compositions and Administrations Thereof App 20150164881 - Van Goor; Fredrick F. ; et al.	2015-06-18
Pharmaceutical Compositions And Administrations Thereof App 20150164883 - Van Goor; Fredrick F. ; et al.	2015-06-18
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof App 20150140094 - Verwijs; Marinus Jacobus ; et al.	2015-05-21
Pharmaceutical Compositions And Administrations Thereof App 20150141459 - Van Goor; Fredrick F. ; et al.	2015-05-21
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarbox- amide and administration thereof Grant 9,012,496 - Alargova , et al. April 21, 2	2015-04-21
Methods For Treating Inflammatory Diseases And Pharmaceutical Combinations Useful Therefor App 20140243273 - Kadiyala; Irina Nikolaevna ; et al.	2014-08-28
Formulations Of (r)-1-(2,2-difluorobenzo[d] [1,3] Dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- Pan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide App 20140094499 - ALARGOVA; ROSSITZA GUEORGUIEVA ; et al.	2014-04-03
Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6- -fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarbox- amide and administration thereof App 20140088160 - ALARGOVA; ROSSITZA GUEORGUIEVA ; et al.	2014-03-27
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof App 20140023706 - Verwijs; Marinus Jacobus ; et al.	2014-01-23
Pharmaceutical Compositions And Administrations Thereof App 20130338188 - Van Goor; Fredrick F. ; et al.	2013-12-19
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- pan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide Grant 8,563,593 - Alargova , et al. October 22, 2	2013-10-22
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof Grant 8,552,034 - Verwijs , et al. October 8, 2	2013-10-08
Pharmaceutical Compositions And Administrations Thereof App 20130158071 - Van Goor; Fredrick F. ; et al.	2013-06-20
Pharmaceutical Compositions And Administrations Thereof App 20130143919 - Van Goor; Fredrick F. ; et al.	2013-06-06
Pharmaceutical Compositions And Administrations Thereof App 20130131107 - Van Goor; Fredrick F. ; et al.	2013-05-23
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic Acid And Administration Thereof App 20130095181 - Verwijs; Marinus Jacobus ; et al.	2013-04-18
Pharmaceutical Compositions Of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-meth- Ylpropan-2-yl)-1h-indol-5-yl) Cyclopropanecarboxamide And Administration Thereof App 20120046330 - Alargova; Rossitza Gueorguieva ; et al.	2012-02-23
Formulations Of (r)-1-(2,2-difluorobenzo[d] [1,3] Dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpro- Pan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide App 20120015999 - Alargova; Rossitza Gueorguieva ; et al.	2012-01-19
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof App 20110256220 - Verwijs; Marinus Jacobus ; et al.	2011-10-20
Controlled Release Formulations App 20110021598 - Kadiyala; Irina Nikolaevna ; et al.	2011-01-27
Controlled release formulations App 20080070972 - Kadiyala; Irina Nikolaevna ; et al.	2008-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.